<?xml version="1.0" encoding="UTF-8"?>
<document id="DDI-DrugBank.d253">
    <sentence id="DDI-DrugBank.d253.s0" text="Beta-adrenergic blocking agents: concurrent use may blunt the response to arbutamine.">
        <entity id="DDI-DrugBank.d253.s0.e0" charOffset="0-30"
            type="group" text="Beta-adrenergic blocking agents"/>
        <entity id="DDI-DrugBank.d253.s0.e1" charOffset="74-83"
            type="drug" text="arbutamine"/>
    </sentence>
    <sentence id="DDI-DrugBank.d253.s1" text="Beta-adrenergic blocking agents should be withdrawn at least 48 hours before conducting an arbutamine-mediated stress test.">
        <entity id="DDI-DrugBank.d253.s1.e0" charOffset="0-30"
            type="group" text="Beta-adrenergic blocking agents"/>
        <entity id="DDI-DrugBank.d253.s1.e1" charOffset="91-100"
            type="drug" text="arbutamine"/>
        <ddi id="DDI-DrugBank.d253.s1.d0" e1="DDI-DrugBank.d253.s1.e0"
            e2="DDI-DrugBank.d253.s1.e1" type="advise"/>
    </sentence>
    <sentence id="DDI-DrugBank.d253.s2" text="Antiarrhythmic agents, class I (such as flecainide, lidocaine, or quinidine): concurrent use with arbutamine may have a proarrhythmic effect.">
        <entity id="DDI-DrugBank.d253.s2.e0" charOffset="0-29"
            type="drug" text="Antiarrhythmic agents, class I"/>
        <entity id="DDI-DrugBank.d253.s2.e1" charOffset="40-49"
            type="drug" text="flecainide"/>
        <entity id="DDI-DrugBank.d253.s2.e2" charOffset="52-60"
            type="drug" text="lidocaine"/>
        <entity id="DDI-DrugBank.d253.s2.e3" charOffset="66-74"
            type="drug" text="quinidine"/>
        <entity id="DDI-DrugBank.d253.s2.e4" charOffset="98-107"
            type="drug" text="arbutamine"/>
    </sentence>
    <sentence id="DDI-DrugBank.d253.s3" text="Antidepressants (tricyclic), atropine or other anticholinergic agents, or digitalis glycosides: concurrent use with arbutamine may produce additive inotropic and/or chronotropic effects.">
        <entity id="DDI-DrugBank.d253.s3.e0" charOffset="0-14"
            type="group" text="Antidepressants"/>
        <entity id="DDI-DrugBank.d253.s3.e1" charOffset="17-25"
            type="group" text="tricyclic"/>
        <entity id="DDI-DrugBank.d253.s3.e2" charOffset="29-36"
            type="drug" text="atropine"/>
        <entity id="DDI-DrugBank.d253.s3.e3" charOffset="47-68"
            type="group" text="anticholinergic agents"/>
        <entity id="DDI-DrugBank.d253.s3.e4" charOffset="74-93"
            type="group" text="digitalis glycosides"/>
        <entity id="DDI-DrugBank.d253.s3.e5" charOffset="116-125"
            type="drug" text="arbutamine"/>
    </sentence>
</document>
